X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2477) 2477
Book Review (665) 665
Publication (296) 296
Book Chapter (32) 32
Conference Proceeding (14) 14
Book / eBook (6) 6
Dissertation (4) 4
Magazine Article (4) 4
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2147) 2147
animals (1385) 1385
humans (1286) 1286
neurosciences (1028) 1028
male (939) 939
serotonin (877) 877
pharmacology & pharmacy (693) 693
psychiatry (652) 652
mice (584) 584
female (543) 543
rats (504) 504
receptor, serotonin, 5-ht2c - genetics (380) 380
schizophrenia (354) 354
adult (302) 302
receptors (299) 299
receptors, serotonin - genetics (297) 297
brain (288) 288
serotonin - metabolism (276) 276
research (259) 259
biochemistry & molecular biology (249) 249
dopamine (246) 246
receptor, serotonin, 5-ht2c - metabolism (235) 235
clinical neurology (221) 221
5-ht (214) 214
genotype (210) 210
rodents (210) 210
article (209) 209
neurons (205) 205
receptors, serotonin - metabolism (199) 199
disease models, animal (197) 197
gene expression (197) 197
middle aged (197) 197
neurology (197) 197
serotonin receptors (195) 195
5-ht2c receptor (193) 193
pharmacology (191) 191
rats, sprague-dawley (190) 190
brain - metabolism (189) 189
genetic aspects (188) 188
receptor (185) 185
analysis (184) 184
physiological aspects (183) 183
obesity (179) 179
biomedicine (172) 172
mice, inbred c57bl (172) 172
multidisciplinary sciences (172) 172
serotonin receptor agonists - pharmacology (172) 172
schizophrenia - drug therapy (171) 171
depression (168) 168
expression (161) 161
prefrontal cortex (160) 160
medicine (158) 158
antipsychotic agents - adverse effects (157) 157
receptor, serotonin, 5-ht2c (157) 157
polymorphism, genetic (156) 156
dose-response relationship, drug (155) 155
rna, messenger - metabolism (155) 155
anxiety (154) 154
antipsychotic agents - therapeutic use (150) 150
research article (150) 150
behavior (148) 148
phenols (148) 148
polymorphism (147) 147
proteins (147) 147
genetics (145) 145
mice, knockout (142) 142
pharmacogenetics (141) 141
antidepressants (140) 140
mental disorders (140) 140
cell biology (136) 136
rna editing (136) 136
serotonin antagonists - pharmacology (135) 135
signal transduction (130) 130
drugs (129) 129
risk factors (129) 129
serotonin s2 receptors (127) 127
messenger-rna (125) 125
association (119) 119
genes (119) 119
psychopharmacology (119) 119
biology (118) 118
genetics & heredity (118) 118
science (118) 118
rats, wistar (117) 117
antipsychotic agents - pharmacology (116) 116
central-nervous-system (116) 116
rat-brain (116) 116
health aspects (115) 115
nervous system (114) 114
pharmacology/toxicology (113) 113
time factors (113) 113
gene (112) 112
in-vivo (112) 112
double-blind (110) 110
stress (110) 110
alleles (107) 107
schizophrenia - genetics (107) 107
clozapine (106) 106
induced weight-gain (103) 103
polymorphism, single nucleotide (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2476) 2476
Chinese (8) 8
Russian (5) 5
French (4) 4
German (3) 3
Japanese (3) 3
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 07/2012, Volume 287, Issue 28, pp. 23604 - 23614
Journal Article
JOURNAL OF BIOLOGICAL CHEMISTRY, ISSN 0021-9258, 05/2015, Volume 290, Issue 18, pp. 11537 - 11546
Journal Article
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2013, Volume 123, Issue 12, pp. 5061 - 5070
Energy and glucose homeostasis are regulated by central serotonin 2C receptors. These receptors are attractive pharmacological targets for the treatment of... 
POMC NEURONS | SYSTEM | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | HEPATIC INSULIN SENSITIVITY | LEPTIN ACTION | DRUGS | MICE | D-FENFLURAMINE | GLUCAGON | HYPOTHALAMUS | Serotonin - physiology | Body Weight | Male | Glucagon - blood | Pro-Opiomelanocortin - physiology | Hyperglycemia - genetics | Serotonin Receptor Agonists - pharmacology | Receptor, Serotonin, 5-HT2C - physiology | Neurons - physiology | Hyperinsulinism - genetics | Female | Obesity - etiology | Energy Metabolism - physiology | Pro-Opiomelanocortin - genetics | Insulin Secretion | Drug Resistance | Hyperinsulinism - metabolism | Recombinant Fusion Proteins - biosynthesis | Hyperphagia - etiology | Dietary Sucrose - toxicity | Appetite Depressants - pharmacology | Insulin Resistance | Feeding Behavior - drug effects | Mice, Knockout | Hyperglycemia - metabolism | Insulin - metabolism | Animals | Homeostasis - physiology | Pro-Opiomelanocortin - biosynthesis | Glucose - metabolism | Glucagon - metabolism | Mice | Receptor, Serotonin, 5-HT2C - genetics | Dietary Fats - toxicity | Receptor, Serotonin, 5-HT2C - deficiency | Glucose metabolism | Energy metabolism | Receptors | Bioenergetics | Serotonin | Weight loss | Physiological aspects | Research | Anorexia | Neurons | Mortality | Homeostasis | Glucose | Grants | Insulin | Experiments | Nutrition research | Weight control | Rodents | Food | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2007, Volume 27, Issue 26, pp. 6956 - 6964
The dynamic interplay between serotonin [5-hydroxytryptamine (5-HT)] neurotransmission and the hypothalamic-pituitary-adrenal (HPA) axis has been extensively... 
Paraventricular nucleus of the hypothalamus | receptor | mCPP | Serotonin | Corticosterone | 5-HT | Corticotropin-releasing hormone | corticotropin-releasing hormone | 5-HT2C RECEPTORS | 5-HT2C receptor | FOS-LIKE IMMUNOREACTIVITY | paraventricular nucleus of the hypothalamus | NEUROSCIENCES | MICE LACKING | REGULATING ENERGY HOMEOSTASIS | serotonin | CORTICOTROPIN-RELEASING-FACTOR | SERUM CORTICOSTERONE CONCENTRATION | PARAVENTRICULAR NUCLEUS | CRF RELEASE | GENE-EXPRESSION | corticosterone | MELANOCORTIN PATHWAYS | Receptor, Serotonin, 5-HT2C - metabolism | Adrenal Cortex Hormones - secretion | Male | Receptor, Serotonin, 5-HT1D - genetics | RNA, Messenger - metabolism | Serotonin - pharmacology | Hypothalamo-Hypophyseal System - secretion | Stress, Physiological - metabolism | Neurosecretory Systems - metabolism | Adrenal Cortex Hormones - metabolism | RNA, Messenger - drug effects | Hypothalamo-Hypophyseal System - drug effects | Pituitary-Adrenal System - secretion | Pituitary-Adrenal System - drug effects | Pituitary-Adrenal System - metabolism | Stress, Physiological - genetics | Mice, Inbred C57BL | Receptor, Serotonin, 5-HT1D - metabolism | Rats | Stress, Physiological - physiopathology | Rats, Sprague-Dawley | Corticotropin-Releasing Hormone - metabolism | Down-Regulation - genetics | Hypothalamo-Hypophyseal System - metabolism | Corticotropin-Releasing Hormone - secretion | Mice, Knockout | Paraventricular Hypothalamic Nucleus - drug effects | Animals | Serotonin - metabolism | Paraventricular Hypothalamic Nucleus - metabolism | Paraventricular Hypothalamic Nucleus - secretion | Neurosecretory Systems - drug effects | Mice | Receptor, Serotonin, 5-HT2C - genetics | Serotonin 5-HT2 Receptor Agonists | Index Medicus
Journal Article
PLOS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, pp. e32266 - e32266
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2016, Volume 26, Issue 8, pp. 1327 - 1337
Abstract The present study investigated interactions between the novel psychoactive tryptamines DiPT, 4-OH-DiPT, 4-OH-MET, 5-MeO-AMT, and 5-MeO-MiPT at... 
Internal Medicine | Psychiatry | DMT | Psilocybin | Tryptamines | LSD | Hallucinogens | Mescaline | DESIGNER CATHINONES | SEROTONIN TRANSPORTER | Psitocybin | DOSE-RESPONSE | MONOAMINE TRANSPORTER | PREPULSE INHIBITION | PSYCHIATRY | NEUROSCIENCES | CLINICAL NEUROLOGY | LYSERGIC-ACID DIETHYLAMIDE | HEAD-TWITCH RESPONSE | IN-VITRO | DOUBLE-BLIND | PHARMACOLOGICAL PROFILE | PHARMACOLOGY & PHARMACY | NIH 3T3 Cells | Membrane Transport Modulators - chemistry | Receptor, Serotonin, 5-HT2A - genetics | Vesicular Monoamine Transport Proteins - metabolism | Receptor, Serotonin, 5-HT2B - metabolism | Humans | Receptor, Serotonin, 5-HT2C - metabolism | Serotonin 5-HT2 Receptor Agonists - pharmacology | Structure-Activity Relationship | Receptor, Serotonin, 5-HT2A - chemistry | Receptor, Serotonin, 5-HT2B - genetics | Tryptamines - pharmacology | Membrane Transport Modulators - pharmacology | Psychotropic Drugs - pharmacology | HEK293 Cells | Molecular Structure | Psychotropic Drugs - metabolism | Radioligand Assay | Serotonin 5-HT2 Receptor Agonists - metabolism | Recombinant Proteins - metabolism | Cell Survival - drug effects | Tryptamines - chemistry | Hallucinogens - pharmacology | Hallucinogens - metabolism | Vesicular Monoamine Transport Proteins - antagonists & inhibitors | Hallucinogens - chemistry | Recombinant Proteins - chemistry | Psychotropic Drugs - chemistry | Serotonin 5-HT2 Receptor Agonists - chemistry | Receptor, Serotonin, 5-HT2B - chemistry | Membrane Transport Modulators - metabolism | Animals | Tryptamines - metabolism | Receptor, Serotonin, 5-HT2C - chemistry | Vesicular Monoamine Transport Proteins - genetics | Ligands | Mice | Receptor, Serotonin, 5-HT2C - genetics | Biogenic Monoamines - metabolism | Kinetics | Receptor, Serotonin, 5-HT2A - metabolism | Cytokinins | Alkaloids | Hallucinogenic drugs | Comparative analysis | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 9/2008, Volume 199, Issue 4, pp. 549 - 568
Serotonin (5-HT)2C receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive... 
Antidepressant | Neurosciences | Biomedicine | BDNF | 5-HT 2C receptor | Pharmacology/Toxicology | Psychiatry | Anxiolytic | Ventral tegmental area | Stress | Locus ceruleus | receptor | 5-HT | stress | locus ceruleus | PSYCHIATRY | antidepressant | 5-HT2C receptor | ANXIETY-LIKE BEHAVIOR | 2C RECEPTOR | NEUROSCIENCES | OBSESSIVE-COMPULSIVE DISORDER | M-CHLOROPHENYLPIPERAZINE | ventral tegmental area | MILD STRESS MODEL | 5-HYDROXYTRYPTAMINE(2C) RECEPTORS | IN-VIVO | SEROTONIN (5-HT)(2C) RECEPTORS | PHARMACOLOGY & PHARMACY | anxiolytic | DISCRIMINATIVE STIMULUS PROPERTIES | 3 ANIMAL-MODELS | Cricetulus | Rats, Wistar | Receptor, Serotonin, 5-HT2B - metabolism | Receptor, Serotonin, 5-HT2C - metabolism | Motor Activity - drug effects | Male | Serotonin 5-HT2 Receptor Antagonists | Indoles - metabolism | Receptor, Serotonin, 5-HT2B - drug effects | Swimming - psychology | Penile Erection - drug effects | Conflict (Psychology) | Indoles - pharmacology | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Interpersonal Relations | CHO Cells | Cricetinae | Anti-Anxiety Agents - pharmacology | Rats | Vocalization, Animal | Serotonin Antagonists - pharmacology | Binding, Competitive - drug effects | Animals | Pyridines - metabolism | Signal Transduction - drug effects | Recombinant Proteins - drug effects | Biogenic Monoamines - physiology | Serotonin Antagonists - metabolism | Cell Proliferation - drug effects | Mice | Pyridines - pharmacology | Receptor, Serotonin, 5-HT2C - genetics | Aggression - drug effects | Prescription drugs | Mental depression | Anxieties | Rodents | Psychopharmacology | Animal cognition | Index Medicus
Journal Article